Shire boosts Laval facility with new research centre

Guest Contributor
December 2, 2002

Shire Pharmaceuticals Group plc is investing $28 million in a new global vaccine research centre at its Laval PQ facility (formerly BioChem Pharma). The $28-million investment includes a $5-million contribution from Technology Partnerships Canada, which has not yet been publicly confirmed....


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.